Special Seminar
Cancer Updates: from UPR to Checkpoint Inhibitors
Dr. Costas Koumenis
University of Pennsylvania
“The role of the UPR/ISR effector ATF4 in tumor progression and metastasis”
and
Dr. Michael Karin
University of California, San Diego
“How to Enhance the Response to Checkpoint Inhibitors”